ADMA Biologics Competitors and Similar CompaniesClear all
CorMedix's competitors and similar companies include Autolus and Longboard Pharmaceuticals.
 CorMedix CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease. |  Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. |  Longboard Pharmaceuticals Longboard Pharmaceuticals, Inc. (Longboard) is a biopharmaceutical company focused on developing transformative medicines for neurological diseases. | |
Founding Date | Founding Date 2006 | Founding Date 2014 | Founding Date 2020 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Berkeley Heights, US HQ | Locations London, GB HQ London, GB | Locations San Diego, US HQ San Diego, US |
Employees | Employees 3036% increase | Employees 647 | Employees 5056% increase |
Valuation ($) | Valuation ($) 749.2 m | Valuation ($) 1.2 b | Valuation ($) 2.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) $311.7m (FY, 2025) | Revenue (est.) $75.4m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $22.1m (FY, 2025) | Cost of goods $86.6m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $275.7m (FY, 2025) | Gross profit ($10.7m) (FY, 2025) | Gross profit N/A |
Net income | Net income $163.1m (FY, 2025) | Net income ($287.5m) (FY, 2025) | Net income ($54.4m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 11.5m | Total funding raised $ 281.7m | Total funding raised $ 56m |
For sources of this data, please see the company profile
View Company Profiles
Autolus
HQ
London, GB
Employees
647
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
View companyLongboard Pharmaceuticals
HQ
San Diego, US
Employees
50
Longboard Pharmaceuticals, Inc. (Longboard) is a biopharmaceutical company focused on developing transformative medicines for neurological diseases.
View company